α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study.
第一作者:
Michio,Shimabukuro
第一单位:
Department of Diabetes, Endocrinology, and Metabolism, Fukushima Medical University, Fukushima, Japan.;Department of Cardio-Diabetes Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
作者:
医学主题词
1-脱氧野尻霉素(1-Deoxynojirimycin);急性冠状动脉综合征(Acute Coronary Syndrome);成年人(Adult);老年人(Aged);血糖(Blood Glucose);糖尿病, 2型(Diabetes Mellitus, Type 2);女(雌)性(Female);葡萄糖(Glucose);心率(Heart Rate);人类(Humans);降血糖药(Hypoglycemic Agents);男(雄)性(Male);中年人(Middle Aged);治疗结果(Treatment Outcome)
DOI
10.1186/s12933-017-0571-1
PMID
28683829
发布时间
2018-11-13
- 浏览56
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



